Compound Summary
Compound Information
Vitexin
Compound Name: | Vitexin |
Compound CID: | 5280441 |
Synonyms: | Vitexin 3681-93-4 Apigenin 8-C-glucoside Vitxein UNII-9VP70K75OK More... |
Iupac Name: | 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one |
InChI: | InChI=1S/C21H20O10/c22-7-14-17(27)18(28)19(29)21(31-14)16-11(25)5-10(24)15-12(26)6-13(30-20(15)16)8-1-3-9(23)4-2-8/h1-6,14,17-19,21-25,27-29H,7H2/t14-,17-,18+,19-,21+/m1/s1 |
InChIKey: | SGEWCQFRYRRZDC-VPRICQMDSA-N |
Canonical Smiles: | C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)C4C(C(C(C(O4)CO)O)O)O)O |
Isomeric Smiles: | C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O |
Molecular Weight: | 432.4 |
Molecular Formula: | C21H20O10 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Vitexin
Molecular Weight: | 432.4 |
Molecular Formula: | C21H20O10 |
Hydrogen Bond Donor Count: | 7 |
Hydrogen Bond Acceptor Count: | 10 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 31 |
Complexity: | 690 |
Synonyms
Vitexin
| Vitexin | Vitexin |
|---|---|
Vitexin |
3681-93-4 |
Apigenin 8-C-glucoside |
Vitxein |
UNII-9VP70K75OK |
9VP70K75OK |
CHEBI:16954 |
MFCD00017456 |
4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-beta-D-glucopyranosyl-2-(4-hydroxyphenyl)- |
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-ylchromen-4-one |
Flavone, 8-D-glucosyl-4,5,7-trihydroxy- |
(1S)-1,5-anhydro-1-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl-D-glucitol |
8-beta-D-Glucopyranosyl-apigenin |
8-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
EINECS 222-963-8 |
Vitexin,(S) |
Vitexin, analytical standard |
SCHEMBL25277 |
CHEMBL487417 |
DTXSID90190287 |
4H-1-Benzopyran-4-one, 8-.beta.-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)- |
Apigenin 8-C-.beta.-D-glucoside |
ACT02625 |
HY-N0013 |
ZINC4245684 |
BDBM50362886 |
s9192 |
AKOS025311479 |
AC-6086 |
CCG-208516 |
4H-1-Benzopyran-4-one, 8-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)- |
NCGC00163642-01 |
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-ylchromen-4-one |
AS-55909 |
(hydroxymethyl)tetrahydro-2H-pyran-2-yl)- |
CS-0007090 |
N1319 |
V0191 |
C01460 |
681V934 |
Q259075 |
Vitexin, primary pharmaceutical reference standard |
Q-100437 |
8-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6- |
5,7,4-Trihydroxyflavone 8-C-.beta.-D-glucopyranoside |
Vitexin, United States Pharmacopeia (USP) Reference Standard |
4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-.beta.-D-glucopyranosyl-2-(4-hydroxyphenyl)- |
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-4H-chromen-4-one |
Experimental Data
Vitexin
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 100 | umol/L | 17.3 | 19.2 | 10.98 | 24.7 | 28.1 | 0.14 | S | N2 | 35413150 | Active | |
| Caenorhabditis elegans | 50 | umol/L | 17.3 | 18.2 | 5.2 | 24.7 | 26.9 | 0.09 | S | N2 | 35413150 | Active | |
| Caenorhabditis elegans | 100 | umol/L | 13.5 | 15.8 | 17.2 | 19 | 21 | 0.11 | S | N2 | 26535084 | Active | |
| Caenorhabditis elegans | 50 | umol/L | 13.5 | 14.6 | 8 | 19 | 20 | 0.05 | S | N2 | 26535084 | Active | |
| Caenorhabditis elegans | 100 | umol/L | 17.2 | 10.53 | S | N2 | 33683565 | Active | |||||
| Caenorhabditis elegans | 50 | umol/L | 8 | 5.26 | S | N2 | 33683565 | Active |
Experimental Data Visualization
Vitexin
Statistics Data
Vitexin
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 17.2 | 10.53 | 3 | 6 |
Statistics Data Visualization
Vitexin
